CONMED Corp Files 8-K on Officer/Director Changes
Ticker: CNMD · Form: 8-K · Filed: Sep 9, 2025 · CIK: 816956
Sentiment: neutral
Topics: officer-changes, director-changes, compensation
Related Tickers: CNMD
TL;DR
CONMED's 8-K shows leadership changes and new officer compensation plans.
AI Summary
CONMED Corporation filed an 8-K on September 9, 2025, reporting events as of September 8, 2025. The filing primarily concerns the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in CONMED's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key personnel and executive compensation can signal internal shifts that may affect future performance or strategy.
Key Numbers
- 001-39218 — SEC File Number (Identifies CONMED Corporation's filing with the SEC.)
- 16-0977505 — IRS Employer Identification No. (Tax identification number for CONMED Corporation.)
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Largo, Florida (location) — Principal executive offices
FAQ
What specific officer(s) or director(s) departed CONMED Corporation?
The filing indicates the departure of directors or certain officers but does not name the specific individuals in the provided text.
Who were elected as new directors for CONMED Corporation?
The filing states the election of directors occurred, but the names of the newly elected directors are not detailed in the provided text.
Were any new officers appointed at CONMED Corporation?
Yes, the filing mentions the appointment of certain officers, but their specific roles and names are not provided in the excerpt.
What is the nature of the compensatory arrangements for certain officers mentioned in the filing?
The filing notes that compensatory arrangements for certain officers are a subject of this report, but the specifics of these arrangements are not detailed in the provided text.
What is the filing date and the date of the earliest event reported for this 8-K?
The filing date is September 9, 2025, and the date of the earliest event reported is September 8, 2025.
Filing Stats: 821 words · 3 min read · ~3 pages · Grade level 11.1 · Accepted 2025-09-09 16:11:05
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by che
- $134,766, b — directors with a value of approximately $134,766, based on a Black Scholes valuation, which
Filing Documents
- form8k-34670_cnmd.htm (8-K) — 27KB
- ex99-1.htm (EX-99.1) — 8KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001174947-25-001185.txt ( ) — 204KB
- cnmd-20250908.xsd (EX-101.SCH) — 3KB
- cnmd-20250908_lab.xml (EX-101.LAB) — 33KB
- cnmd-20250908_pre.xml (EX-101.PRE) — 22KB
- form8k-34670_cnmd_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits The following exhibits are included herewith: Exhibit No. Description of Exhibit 99.1 Press release dated September 9, 2025, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 9, 2025 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance & Chief Financial Officer